(Q34385440)

1 August 2017

1 reference

title

What is the "best" platinum: cisplatin, carboplatin, or oxaliplatin? (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

1 reference

Lokich J

1

1 reference

1 August 2017

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

19

1 reference

1 August 2017

756-760

1 reference

1 August 2017

7

1 reference

Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin

1 August 2017

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100106152

Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: a Mid-Atlantic Oncology Program Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100106152

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100106152

Phase-I study of protracted infusion of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100106152

Carboplatin versus cisplatin in solid tumors: an analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100106152

Multifractionated dosing for cancer chemotherapy: a novel schedule and a work in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100106152

Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100106152

21 January 2018

Identifiers

DOI

10.1081/CNV-100106152

1 reference

1 August 2017

1 reference

PubMed ID

11577818